Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19.
作者信息
Lechien J R, Chiesa-Estomba C M, Hans S, Saussez S
机构信息
From the, Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
Department of Otolaryngology-Head & Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.
出版信息
J Intern Med. 2021 Aug;290(2):464-465. doi: 10.1111/joim.13257. Epub 2021 Feb 15.
Abstract
摘要
相似文献
1
Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19.与新冠病毒相关的长期嗅觉丧失患者的病理生理机制及治疗
J Intern Med. 2021 Aug;290(2):464-465. doi: 10.1111/joim.13257. Epub 2021 Feb 15.
2
Management of Post-Infectious Anosmia and Hyposmia: A Systematic Review.感染后嗅觉缺失和嗅觉减退的管理：系统评价。
Ann Otol Rhinol Laryngol. 2023 Jul;132(7):806-817. doi: 10.1177/00034894221118186. Epub 2022 Aug 12.
3
[Loss of smell, a preliminary indicator of COVID-19].[嗅觉丧失，新冠病毒病的一个初步指标]
Rev Med Inst Mex Seguro Soc. 2021 Feb 2;59(1):4-6. doi: 10.24875/RMIMSS.M21000046.
4
Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.新型冠状病毒肺炎与嗅觉功能障碍的病理生理学关系：系统综述。
Braz J Otorhinolaryngol. 2022 Sep-Oct;88(5):794-802. doi: 10.1016/j.bjorl.2021.04.001. Epub 2021 Apr 25.
5
Olfactory disorder in patients infected with SARS-CoV-2.感染 SARS-CoV-2 患者的嗅觉障碍。
J Microbiol Immunol Infect. 2021 Oct;54(5):992-996. doi: 10.1016/j.jmii.2020.08.010. Epub 2020 Aug 20.
6
The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients.鼻内免疫球蛋白在新冠病毒肺炎患者嗅觉功能恢复中的作用
Am J Otolaryngol. 2022 May-Jun;43(3):103301. doi: 10.1016/j.amjoto.2021.103301. Epub 2021 Dec 2.
7
[The alleged mechanisms of olfactory disorders in the new coronavirus infection].[新型冠状病毒感染中嗅觉障碍的假定机制]
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(2):7-11. doi: 10.17116/jnevro20231230217.
8
Residual olfactory dysfunction in coronavirus disease 2019 patients after long term recovery.新冠肺炎患者长期康复后残留嗅觉功能障碍。
J Clin Neurosci. 2021 Nov;93:31-35. doi: 10.1016/j.jocn.2021.07.050. Epub 2021 Jul 28.
9
Anosmia and loss of smell in the era of covid-19.新冠疫情时代的嗅觉丧失与嗅觉减退
BMJ. 2020 Jul 21;370:m2808. doi: 10.1136/bmj.m2808.
10
[From pathophysiology to therapeutic management of loss of smell in Covid-19].[从新冠病毒感染嗅觉丧失的病理生理学到治疗管理]
Rev Prat. 2021 Jan;71(1):13-19.
引用本文的文献
1
Recovery Patterns of COVID-19 Related Smell Disorders: An Analysis of the Available Evidence.新型冠状病毒肺炎相关嗅觉障碍的恢复模式：现有证据分析
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):4179-4189. doi: 10.1007/s12070-023-04005-8. Epub 2023 Jul 3.
2
Prevalence of Self-Reported Anosmia and Ageusia in Elderly Patients Who Had Been Previously Hospitalized by SARS-CoV-2: The LONG-COVID-EXP Multicenter Study.曾因感染新型冠状病毒严重急性呼吸综合征（SARS-CoV-2）而住院的老年患者中自我报告的嗅觉丧失和味觉丧失的患病率：长期新冠后遗症多中心研究
J Clin Med. 2023 Jun 29;12(13):4391. doi: 10.3390/jcm12134391.
本文引用的文献
1
Long-term recovery from COVID-19 anosmia: Promising findings and unanswered questions.COVID-19 嗅觉丧失的长期恢复：有希望的发现和未解决的问题。
J Intern Med. 2021 Aug;290(2):462-463. doi: 10.1111/joim.13247. Epub 2021 Feb 12.
2
Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.口服皮质类固醇和嗅觉训练治疗 COVID-19 相关嗅觉丧失的疗效和安全性。
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3113-3117. doi: 10.1007/s00405-020-06520-8. Epub 2021 Jan 9.
3
Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients.嗅觉功能障碍的患病率和 6 个月的恢复情况：1363 例 COVID-19 患者的多中心研究。
J Intern Med. 2021 Aug;290(2):451-461. doi: 10.1111/joim.13209. Epub 2021 Jan 5.
4
Reinfection risk of novel coronavirus (COVID-19): A systematic review of current evidence.新型冠状病毒（COVID-19）的再感染风险：当前证据的系统评价
World J Virol. 2020 Dec 15;9(5):79-90. doi: 10.5501/wjv.v9.i5.79.
5
Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients.COVID-19 患者持续性嗅觉障碍的皮质类固醇治疗疗效。
Rhinology. 2021 Feb 1;59(1):21-25. doi: 10.4193/Rhin20.515.
6
Loss of smell in patients with COVID-19: MRI data reveal a transient edema of the olfactory clefts.COVID-19 患者嗅觉丧失：MRI 数据显示嗅裂短暂性水肿。
Neurology. 2020 Dec 8;95(23):e3145-e3152. doi: 10.1212/WNL.0000000000010806. Epub 2020 Sep 11.
7
ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection.头颈部区域的ACE2蛋白图谱：新型冠状病毒感染之谜
Biology (Basel). 2020 Aug 18;9(8):235. doi: 10.3390/biology9080235.
8
ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review.头颈部组织中 ACE2 和 TMPRSS2 的表达：系统评价。
Head Neck Pathol. 2021 Mar;15(1):225-235. doi: 10.1007/s12105-020-01212-5. Epub 2020 Aug 20.
9
Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic.共识声明。COVID-19 大流行背景下耳鼻喉科的皮质类固醇治疗。
Eur Ann Otorhinolaryngol Head Neck Dis. 2020 Sep;137(4):315-317. doi: 10.1016/j.anorl.2020.04.014. Epub 2020 May 4.
10
Clinical practice guidelines for the management of olfactory dysfunction - Secondary publication.嗅觉功能障碍管理临床实践指南——二次发表。
Auris Nasus Larynx. 2019 Oct;46(5):653-662. doi: 10.1016/j.anl.2019.04.002. Epub 2019 May 7.
Zotero 插件